Navigation Links
Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials to be Presented at the 2013 San Antonio Breast Cancer Conference
Date:9/9/2013

LAWRENCEVILLE, N.J., Sept. 9, 2013 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced the presentation of the combined clinical study results from the Company's Phase I DIGNITY study and the Duke University sponsored Phase I trial of ThermoDox® plus hyperthermia in Breast Cancer Recurrences at the Chest Wall (BCRCW) at the 2013 San Antonio Breast Cancer Conference to be held on December 10 to December 14, 2013. The poster, titled "Novel Targeted Therapy for Breast Cancer Chest Wall Recurrence: Low Temperature Liposomal Doxorubicin and Mild Local Hyperthermia " will be presented by Professor Hope S. Rugo, MD, from the UCSF School of Medicine.  A copy of the poster presentation will be made available on the Company's website following Dr. Rugo's presentation.

The two Phase I studies enrolled patients that had failed previous standard chemotherapy and radiation therapy and have recurrent breast cancer on their chest wall.  There are no effective treatments available for these chest wall tumors.  ThermoDox® in combination with mild hyperthermia was evaluated in these patients in up to six cycles. The studies were designed to determine the Maximum Tolerated Dose (MTD), evaluate safety and determine early effects of ThermoDox® in combination with hyperthermia.  Clinically meaningful responses were reported in 14 of the 23 evaluable patients.  Based on the results from these two Phase I studies, Celsion is currently enrolling up to 40 patients in an open label Phase 2 study. Enrollment is being conducted at 5 US sites.  Further information can be found on the Company's website and at www.clinicaltrials.gov.

"The patients enrolled in both of these Phase I trials have
'/>"/>

SOURCE Celsion Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
2. Celsion Corporation to Hold Second Quarter 2013 Financial Results Conference Call on Thursday, August 8, 2013
3. Celsion Corporation Issues Statement Regarding Misleading Blog Entry
4. Celsion Corporation Reports Year End 2012 Financial Results and Provides Business Update
5. Celsion Corporation to Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013
6. The X-Change Corporation To Announce Corporate Name Change Next Week; New Industry-Driven Branding to Commence For Global Activities, Services, Product Lines, and Website
7. Unilife Corporation To Announce Financial Results For Fiscal Year 2013 Fourth Quarter And Year End On Tuesday, September 10, 2013
8. Arrayit Corporation Holds Successful Meeting with DHK Medical Products CEO
9. MGC Diagnostics Corporation Reports 2013 Third Quarter Operating Results
10. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
11. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  Game-changing serialization ... latest being the European Commission,s ruling on full ... leader and champion of pharmaceutical supply chain ... meeting these mandates and offers several tools to ... countries. From an upcoming webinar in May defining ...
(Date:4/21/2015)... , April 21, 2015  St. Vincent ... to patient care. Already following strict disinfection routines, ... Tru-D SmartUVC to eliminate harmful germs, like Ebola, ... and norovirus that can infect patients during their ... Logo - http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
(Date:4/21/2015)... PAUL, Minn. , April 21, 2015 /PRNewswire/ ... LED surgical headlight at the same time is ... company introduced the Halo LED surgical headlights, LED ... suite. Since then, Enova has been at the ... focused on providing the brightest, lightest and most ...
Breaking Medicine Technology:Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 2Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 3St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3Enova Illumination Celebrates 10th Anniversary at Cutting Edge of LED Surgical Headlight Innovation; Introduces Newest and Brightest LED Surgical Headlight in the World 2Enova Illumination Celebrates 10th Anniversary at Cutting Edge of LED Surgical Headlight Innovation; Introduces Newest and Brightest LED Surgical Headlight in the World 3
... Gov. Rick Snyder for his efforts to put Michigan on ... the Governor stated, "the state of Michigan currently ranks 8th ... percent." It also has the sixth-highest rate of adult asthma ... of chronic conditions, Michiganders also appear to suffer from a ...
... Sept. 14, 2011 Intarcia Therapeutics, Inc. announced today ... 2 clinical study of ITCA 650 (DUROS® subcutaneous continuous ... diabetes at the 47th Annual Meeting of the European ... (Logo:   http://photos.prnewswire.com/prnh/20050301/SFTU126LOGO ) Results ...
Cached Medicine Technology:Statement from the Michigan Society of Anesthesiologists in Response to Governor Snyder's Health & Wellness Announcement 2Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon 2Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon 3Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon 4Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon 5Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon 6
(Date:4/21/2015)... The American Society for Dermatologic Surgery is ... Brandt, M.D., by setting up two memorial funds in ... 1982, died earlier this month at age 65 at ... opportunities for ASDS members, industry and any interested donors ... Brandt held so dear. , “Dr. Brandt was one ...
(Date:4/21/2015)... 2015 NOVAtime Technology, Inc. ( ... and Attendance / Workforce Management solutions, announced its ... American Payroll Association (APA) as well as NetSuite’s ... has been the nation’s payroll authority since 1982, ... and recertification credits. Held at the MGA Grand ...
(Date:4/21/2015)... Saint Louis, MO (PRWEB) April 21, 2015 ... April 29, 2015 from 5:00 to 8:00 pm at the ... Center Drive, Chapel Hill, NC 27599. More than 50 hospitals, ... across the country. All specialties will be represented. Attendees will ... Thompson, Director of Career Fairs for PracticeMatch says ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Atlantic ... the launch of Medicare-Medicaid Dual Eligibles Database, a ... on care provided to the more than 9 ... account for more than $300 billion in annual ... – the same team that also creates the ...
(Date:4/21/2015)... eSight is the only technology in the world that helps ... May 5th, Low Vision Specialists of Maryland and Virginia ... unveiling and demonstration of the technology at 8:30 a.m at ... be the first ophthalmic practice in Maryland to offer the ... be available on the day of the unveiling. , How ...
Breaking Medicine News(10 mins):Health News:ASDS honors the legacy of Dr. Fredric Brandt 2Health News:ASDS honors the legacy of Dr. Fredric Brandt 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 4Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 2Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 3Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 2Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 3Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 3
... Study Reveals the Most Common Reasons Why Total Hip ... thousands of patients undergo total hip replacement surgery in ... disease and other related hip problems. According to ... of The Journal of Bone and Joint Surgery ...
... Jan. 2 Joan Lunden, the nation,s,longest-running morning ... two decades. During her tenure she reported ... two Royal weddings. One of the most,visible ... of her career to,educating Americans about health and ...
... ATLANTA, Jan. 2 Publix, Procter & Gamble, and,Special ... people with,intellectual disabilities achieve their dreams. Now they,re ... Special Olympics. , 1. Support ... by,purchasing your favorite P&G products like Tide, Pampers, Bounty ...
... tips on how to avoid injury while performing winter ... snow from your driveway and sidewalks can be physically ... proper health and safety precautions, says the American Academy ... than 118,000 people were treated in U.S. hospital emergency ...
... keep colds and flu at bay , , FRIDAY, Jan. 2 ... there,s one tidbit that doctors stand by as the best way ... free of germs is one of the simplest and most effective ... other infectious disease, experts say. , "Disease transmission is hand-to-hand combat, ...
... Va.In a study to determine the diagnostic value of ... cancer, researchers were able for the first time to ... and normal residual thyroid tissue directly after surgery. , ... an article in the January issue of The ...
Cached Medicine News:Health News:Replacing Your Total Hip Replacement 2Health News:Replacing Your Total Hip Replacement 3Health News:Joan Lunden Inks Three-Year Deal to Host Health Corner(R) Television Series 2Health News:'Be A Fan' of Special Olympics Throughout January 2Health News:Shovel Snow Safely 2Health News:To Protect Yourself, Wash Those Germs Away 2Health News:To Protect Yourself, Wash Those Germs Away 3Health News:To Protect Yourself, Wash Those Germs Away 4Health News:Molecular imaging enables earlier, individualized treatment of thyroid cancer 2
The DuraSeal System includes an innovative polyethylene glycol hydrogel sealant and applicator packaged in a single-use kit which can be stored at room temperature for convenience and quick preparati...
Mastisol Liquid Adhesive is a clear, non-irritating, and non-water-soluble liquid adhesive that secures the most difficult dressings for an extended period of time. Mastisol is 7 to 10 times stickier...
GluStitch® is indicated for the closure of uncomplicated skin lacerations where there is little or no tissue loss....
... GE Healthcare is ... in best-in-class analysis programs ... area monitoring device. With ... 12SL, Gender-Specific, and ACI-TIPI, ...
Medicine Products: